DOCSLIB.ORG

FMCSA Medical Examiner Handbook

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
FMCSA Medical Examiner Handbook Federal Motor Carrier Safety Administration (FMCSA) Medical Examiner Handbook As of 2015 this Handbook is no longer in use Table of Contents Introduction .................................................................................................................................................. 7 Part I – The Federal Motor Carrier Safety Administration (FMCSA) ............................................................ 8 About the FMCSA .................................................................................................................................... 8 FMCSA Mission Statement .................................................................................................................. 8 About the Office of Medical Programs ..................................................................................................... 8 The Office of Medical Programs Mission Statement ............................................................................ 8 About the National Registry of Certified Medical Examiners ................................................................... 9 The National Registry of Certified Medical Examiners Mission Statement .......................................... 9 The Medical Examiner ......................................................................................................................... 9 Medical Certification ........................................................................................................................... 10 Privacy and the Medical Examination .................................................................................................... 10 Medical Examination Report Form ..................................................................................................... 10 Medical Examiner’s Certificate ........................................................................................................... 11 Medical Regulations Summary .............................................................................................................. 11 Code of Federal Regulations — LAW ................................................................................................ 11 Medical Standards/Advisory Criteria/Guidelines ................................................................................ 12 Medical Regulations Summary Table ................................................................................................ 12 Exemptions ........................................................................................................................................ 14 Important Definitions .............................................................................................................................. 14 Regulation Definitions ........................................................................................................................ 14 Part II - The Job of Commercial Driving ..................................................................................................... 16 FMCSA Regulates Interstate Commercial Operation ............................................................................ 16 Drivers ................................................................................................................................................ 16 Vehicles .............................................................................................................................................. 16 Truck and Bus Companies ................................................................................................................. 16 State Regulations ............................................................................................................................... 17 The Driver and the Job of Commercial Driving ...................................................................................... 17 The Driver .......................................................................................................................................... 17 The Job of Commercial Driving .......................................................................................................... 18 FMCSA Commercial Driving Facts and Research ................................................................................. 20 Office of Analysis, Research, and Technology .................................................................................. 20 Part III - Medical Examination Guidelines .................................................................................................. 23 About 49 CFR 391.43 ............................................................................................................................ 23 Purpose of Interstate Commercial Driver Physical Examination ........................................................ 23 Driver/Medical Examiner Relationship ................................................................................................... 23 Purpose of Physical Examination ....................................................................................................... 23 The Issue Is Risk ................................................................................................................................ 23 Consider Safety Implications .............................................................................................................. 24 Page 2 of 260 Medical Examiner Do's ...................................................................................................................... 24 Medical Examination Report Form - Overview ...................................................................................... 25 Driver Information ............................................................................................................................... 26 Health History ..................................................................................................................................... 27 Vision ................................................................................................................................................. 33 Hearing ............................................................................................................................................... 34 Blood Pressure/Pulse ......................................................................................................................... 36 Urinalysis ............................................................................................................................................ 38 Physical Examination ......................................................................................................................... 39 Determine Certification Status ........................................................................................................... 43 Certify ................................................................................................................................................. 44 Disqualify ............................................................................................................................................ 48 Issue Medical Examiner's Certificate ................................................................................................. 49 Part IV - Physical Qualification Standards and Advisory Criteria ............................................................... 51 Physical Qualification Standards (Regulations) versus Advisory Criteria (Medical Guidelines) ............ 51 Ongoing Standards and Guidelines Review Process ............................................................................ 51 About 49 CFR 391.41 ............................................................................................................................ 52 Vision ..................................................................................................................................................... 52 Vision Regulation 49 CFR 391.41(b)(10) ........................................................................................... 52 Health History and Physical Examination .......................................................................................... 53 Certification and Documentation ........................................................................................................ 56 Hearing................................................................................................................................................... 59 Hearing Regulation 49 CFR 391.41(b)(11) ........................................................................................ 60 Health History and Physical Examination .......................................................................................... 60 Certification and Documentation ........................................................................................................ 62 Advisory Criteria/Guidance ................................................................................................................ 63 Hypertension .......................................................................................................................................... 64 Blood Pressure (BP) Regulations 49 CFR 391.41(b)(6) and 49 CFR 391.43(f) ................................ 65 Health History and Physical Examination .........................................................................................
Load more

Recommended publications
  • OMS II Medical Skills Competencies
    SOMA OMS II Medical Skills Competencies Exam Checklist #1 Performed Performed Did not satisfactorily less than perform General, Vital Signs, Skin, Hair, and Nails (1 point) satisfactorily (0 point) (0.5 point) GENERAL 1. Introduces self to patient including full name and status (2nd year osteopathic medical student). 2. Demonstrates respect in addressing patient. 3. Washes hands before shaking hands. 4. Washes hands before beginning physical exam. VITAL SIGNS 5. Takes radial pulse rate. 6. Palpates radial pulse bilaterally. 7. Takes respiratory rate. 8. Takes BP, patient seated comfortably, feet on floor, cuff at heart level and arm supported. 9. Explains vital sign results to patient. SKIN 10. Inspects entire skin surface, explaining reason for inspection to patient 11. Demonstrates proper draping to preserve patient modesty. 12. Palpates skin for turgor, texture, and capillary refill. HAIR 13. Notes observed hair distribution on scalp and body. When possible and appropriate, includes pelvic hair distribution. 14. Describes scalp hair color, distribution and character (thick, thin, straight, curly). NAILS 15. Describes nail abnormalities- color, shape, texture, thickness (lines, brittleness, thickening, discoloration, pitting, ridges, spooning) Score ___/15 Student Name: ________________________________ Student Name: _____________________ Community Campus: ________________________________ Signature of Preceptor: _________________________ Name of Preceptor:_______________________ Date of Completion: ______________ Form Updated 7/10/15 SOMA OMS II Medical Skills Competencies Physical Exam Checklist #2: Performed Performed less Did not perform Head, Eyes, CN’s II-XII satisfactorily than (0 point) (1 point) satisfactorily (0.5 point) EYES 1. Visual Acuity (CN II.) 2. Visual Fields to confrontation 3. Extraocular Movements: (CNs - III, IV, VI.) 4.
    [Show full text]
  • An Evaluation of Two Pulse-Type Tests Oe Hearing
    AN EVALUATION OF TWO PULSE-TYPE TESTS OE HEARING Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By THOMAS BROWN ANDERSON, B.S., M. S. The Ohio State University 1952 Approved by: TABLE OE CONTENTS CHAPTER I. INTRODUCTION .... ............. 1 The Problem...................... 7 The Hypotheses ................. 8 Explanation of Terms . ........ 12 II. REVIEW OE LITERATURE ............. 14 III. PROCEDURES........................ 26 Apparatus........................ 26 Stimuli................... .. 28 Subjects ........................ 29 Presentation ................... 30 Scoring of Tests ............... 33 IV. RESULTS AND DISCUSSION........... 34 Part I .......................... 34 Part II ........................ 96 V. CONCLUSIONS ...................... 99 BIBLIOGRAPHY............................ 104 APPENDIX A ............................... 108 APPENDIX B ............................... 110 APPENDIX C............................... 111 APPENDIX D . ............................ 112 APPENDIX E ............................... 113 APPENDIX E ............................... 114 AUTOBIOGRAPHY .......................... 115 ii E09365 LIST OE TABLES TABLE PAGE I. Order of Tests for Each. Group of 10 Subjects . 27 II. Analyses Made and Statistical Methods Used . 36 III. Summary of Tests of Independence and Correla­ tion of Pure-Tone Scores and Speech- Reception Scores ...................... 38 IV. Summary of Eight Analyses of Variance: Measures
    [Show full text]
  • I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St
    2014;22(1):13-18 TCP Translational and Clinical Pharmacology http://dx.doi.org/10.12793/tcp.2014.22.1.13 Clinical Pharmacology Review for Primary Health Care Providers: I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul 137-701, Korea *Correspondence: S. Han; Tel: +82-2-2258-7326, Fax: +82-2-2258-7876, E-mail: [email protected] Received 31 May 2014 Primary health care providers play a critical role in maintaining public health, and the appropri- Accepted 31 May 2014 ate use of pharmaceutical products is one of the major parts of their practice. This series of articles, pISSN: 2289-0882 entitled ‘Clinical Pharmacology Review for Primary Health Care Providers,’ is intended to help pri- mary health care providers select more appropriate prescriptions for frequently used drugs based on up-to-date information. We expect that this effort will contribute to improvements in public health and diminish unnecessary drug use. Introduction tion on the H1 receptor.[8] THERAPEU Antihistamines include some of the most frequently prescribed drugs in the primary health care environment for the symp- Generations and Classes tomatic relief of allergic diseases, the common cold, urticaria, Many primary health care providers are well-informed about T and insomnia.[1-5] The importance of antihistamines has been the different ‘generations’ of antihistamines but not about the ICS TU emphasized as the prevalence of target diseases increases.[6,7] different ‘classes’ characterized according to chemical structure. However, the appropriate use, clinical effectiveness, and target [1] This discrepancy seems reasonable because ‘inter-generation’ T populations for prescription of antihistamines are still a matter differences are more prominent than ‘inter-class’ differences.
    [Show full text]
  • Hearing Screening Training Manual REVISED 12/2018
    Hearing Screening Training Manual REVISED 12/2018 Minnesota Department of Health (MDH) Community and Family Health Division Maternal and Child Health Section 1 2 For more information, contact Minnesota Department of Health Maternal Child Health Section 85 E 7th Place St. Paul, MN 55164-0882 651-201-3760 [email protected] www.health.state.mn.us Upon request, this material will be made available in an alternative format such as large print, Braille or audio recording. 3 Revisions made to this manual are based on: Guidelines for Hearing Screening After the Newborn Period to Kindergarten Age http://www.improveehdi.org/mn/library/files/afternewbornperiodguidelines.pdf American Academy of Audiology, Childhood Screening Guidelines http://www.cdc.gov/ncbddd/hearingloss/documents/AAA_Childhood%20Hearing%2 0Guidelines_2011.pdf American Academy of Pediatrics (AAP), Hearing Assessment in Children: Recommendations Beyond Neonatal Screening http://pediatrics.aappublications.org/content/124/4/1252 4 Contents Introduction .................................................................................................................... 7 Audience ..................................................................................................................... 7 Purpose ....................................................................................................................... 7 Overview of hearing and hearing loss ............................................................................ 9 Sound, hearing, and hearing
    [Show full text]
  • Heart & Vascular Institute
    Sydell and Arnold Miller Family Heart & Vascular Institute 9500 Euclid Avenue, Cleveland, OH 44195 ClevelandClinic.org 2016 Outcomes 17-OUT-413 108369_CCFBCH_Cov_acg.indd 1 8/31/17 12:22 PM Measuring Outcomes Promotes Quality Improvement This project would not have been possible without the commitment and expertise of a team led by Umesh Khot, MD; Mouin Abdallah, MD; Sandra Hays; and Jagina McIntyre. Graphic design and photography were provided by Brian Kohlbacher and Cleveland Clinic’s Center for Medical Art and Photography. © The Cleveland Clinic Foundation 2017 108369_CCFBCH_Cov_acg.indd 2 9/19/17 10:57 AM Measuring and understanding outcomes of medical treatments promotes quality improvement. Cleveland Clinic has created a series of Outcomes books similar to this one for its clinical institutes. Designed for a physician audience, the Outcomes books contain a summary of many of our surgical and medical treatments, with a focus on outcomes data and a review of new technologies and innovations. The Outcomes books are not a comprehensive analysis of all treatments provided at Cleveland Clinic, and omission of a particular treatment does not necessarily mean we do not offer that treatment. When there are no recognized clinical outcome measures for a specific treatment, we may report process measures associated with improved outcomes. When process measures are unavailable, we may report volume measures; a relationship has been demonstrated between volume and improved outcomes for many treatments, particularly those involving surgical and
    [Show full text]
  • FDA Warns That Abuse and Misuse of the Nasal Decongestant Propylhexedrine Causes Serious Harm This Includes Heart and Mental Health Problems Or Death
    FDA warns that abuse and misuse of the nasal decongestant propylhexedrine causes serious harm This includes heart and mental health problems or death 3-25-2021 FDA Drug Safety Communication What safety concern is FDA announcing? The U.S. Food and Drug Administration (FDA) is warning that the abuse and misuse of the over- the-counter (OTC) nasal decongestant propylhexedrine can lead to serious harm such as heart and mental health problems. Some of these complications, which include fast or abnormal heart rhythm, high blood pressure, and paranoia, can lead to hospitalization, disability, or death. Reports of individuals abusing and misusing propylhexedrine have increased in recent years. Propylhexedrine is safe and effective when used as directed. What is FDA doing? We are requesting that all manufacturers of OTC propylhexedrine nasal decongestant inhalers consider product design changes that support its safe use. For example, modifying the product to create a physical barrier that would make tampering with the device and abusing the propylhexedrine inside more difficult. In addition, decreasing the amount of medicine the device contains could also reduce the risk of serious side effects if abused or misused. We continue to evaluate this safety issue and will determine if additional FDA actions are needed. What is propylhexedrine and how can it help me? Propylhexedrine is a nasal decongestant that is available OTC in an inhaler. It is used short term to temporarily relieve nasal congestion due to colds, hay fever, or other upper respiratory allergies. It works by reducing swelling and inflammation of the mucous membrane lining of the nose.
    [Show full text]
  • Modified Release
    Product list Modified Release Our product list consist of the pharmaceuticals, pharmaceutical associations and food in the dosages and forms most required by our customers (please check www.osmopharm.com for more details). Our Research and Development competencies are assuring the flexibility in developing new formulations and forms of the products in list as well as new ones. PRODUCTS RELEASE BULK FORM DOSAGE FINAL FORM THERAPEUTICITY A Acetazolamide SR Pellets 500 mg caps Diuretic Alfacalcidol IR Pellets 1 μg caps Vit D supplement Alfuzosin Hydrochloride SR Powder 2.5 mg – 10 mg tabs Prostatic Hypertrophy agent Allopurinol SR Pellets 300 mg caps Antiurolytic Alprazolam SR Pellets 1 mg caps Anxiolytic Ambroxol HCI SR Pellets 75 mg, 120 mg caps Expectorant Ambroxol HCI SR Resinates 75 mg, 120 mg caps / tabs Expectorant Amitriptyline SR Pellets 25 mg, 50 mg, 75 mg caps Antidepressant Aspirin EC, IR Pellets 100 mg caps Anticoagulant Aspirin EC, IR Microcapsules 100 mg caps / tabs Anticoagulant Atenolol IR Pellets 50 mg caps Antihypertensive Azithromycin IR Pellets 250 mg caps Antibiotic B B-complex Benproperine IR Resinates 25 mg, 50 mg caps / tabs Antitussive Betahistine 2HCI SR Pellets 12 mg, 24 mg, 48 mg caps Vasodilator Bromopride* SR Pellets 20 mg caps Antiemetic Brompheniramine maleate SR Pellets 6 mg, 8 mg, 12 mg caps Antihistaminic C Caffeine SR, IR Pellets 25 mg, 50 mg, 300 mg caps CNS Stimulant Carbetapentane citrate SR Pellets 75 mg caps Antitussive Carbinoxamine maleate SR Pellets 4mg, 6 mg caps Antihistaminic Carbinoxamine
    [Show full text]
  • Film Reviews.6
    Page 75 FILM REVIEWS Black Swan (Dir. Darren Aronofsky) U SA 2010 20th Century Fox International “Done to death, I know. But not like this.” When Vincent Cassel’s leery ballet school director, Thomas Leroy, introduces his cast to the new season’s programme featuring ‘Swan Lake’, he describes how he will reinvent the classic ballet by stripping it down and making it visceral. To do this, he needs a new lead dancer, a woman capable of embodying the characters of both the innocent white swan and the seductive black swan. Darren Aronofsky’s Black Swan takes us on a journey from rehearsal to the stage as a delicate young woman, Nina Sayers (Natalie Portman), prepares for the role and undergoes a tragic transformation. Aronofsky’s latest film doesn’t so much delve into the world of ballet as use it as a pretty setting for his psychological tale of artistic obsession. Nina’s life consists of dancing and not much else. She appears to have no interests outside ballet and lives at home with her mother (Barbara Hershey as a truly terrifying composite of stage mother and classic horror psycho mother), whose grip on her daughter is far tighter than Nina’s own grip on reality. Already unpopular with the other dancers, and with suspicion surrounding her sudden elevation to prima ballerina, the introduction of a new dancer to the company (Mila Kunis) quite literally throws Nina off balance and forces the viewer to reel with her for the rest of the film as she tries unsuccessfully to regain her footing.
    [Show full text]
  • Audiometric Test Procedures
    Audiometric Test Procedures 101 This information is meant to help you better understand the various test procedures as well as some of the terms you might see on an audiometric report. By Larry Medwetsky individual could, in fact, exhibit nor- In the previous issue of Hearing mal hearing acuity across these three Loss Magazine, I provided an over- Anyone who has ever had their frequencies, yet, exhibit a significant view concerning hearing threshold hearing tested should know how hearing loss in the higher frequencies results as recorded on the audiogram to read the audiogram, but that’s (3000-8000 Hz). Thus, it is important and an explanation of the pure-tone easier said than done. Hopefully, to examine the SRT in the context of audiogram. In this article, I will after reading this article you will the other audiometric test findings. describe various test procedures have a greater understanding of the Speech Awareness Threshold that are typically administered in principles discussed and use your (SAT): an audiometric evaluation and what knowledge going forward—be it in Compound words are pre- information the tests provide. reviewing hearing test results you sented, the goal being to determine already have or when discussing your the softest level one can detect the Audiometric Test Procedures results at your next hearing test. presence of words. This test is often Pure-tone Audiometry: Tones of used when an individual’s hearing loss different frequencies are presented; the is so great that the person is unable goal is to find the softest sound level relatively flat hearing losses, and the to recognize/repeat the words, yet is which one can hear (threshold) the average of 500 and 1000 Hz for those aware that words have been presented.
    [Show full text]
  • DDS Parent/Teen Driving Guide
    40-HOUR PARENT/TEEN DRIVING GUIDE GEORGIA DEPARTMENT OF DRIVER SERVICES GOVERNOR’S MESSAGE DDS Customer Service Centers 62 STATE OF GEORGIA DDDS Commissioner OFFICE OF THE GOVERNOR 3 ATLANTA, GA 30334 and Board Messages My Fellow Georgians, 14 AroundSTATE the OF world, GEORGIA Georgia is recognized as a Acknowledgements OFFICE OF THE GOVERNOR beaconATLANTA, of opportunity GA 30334 for economic prosper- ity. Year after year, our state achieves remark- InIntroduction 6 able growth and solidifies its reputation as an unmatched destina- tion to live, work, and thrive. Our success stems from a multitude 10 of factors, including our business-friendly climate, streamlined Sessions 1 & 2 government, and robust infrastructure cohesively connecting our communities. Sessions 3-5 112 As an international transportation hub, Georgia’s navigational sys- Sessions 6 & 7 tem – from Atlanta’s bustling Hartsfield-Jackson Airport, vast Port of 13 Savannah, and efficient network of railroads and roadways – facili- tates travel and commerce across every region. This interconnectiv- Sessions 8-10 15 ity propels the economy forward, connects Georgia’s people, and offers travelers a truly breathtaking experience wherever they go. Sessions 11-13 217 As you navigate the Peach State’s rolling pastures and farmland, traverse impressive heights in mountainous terrain, or coast along- Sessions 14-16 19 side beautiful waterways and diverse wildlife, the Department of Driver Services and I wish you safe passage and encourage you to exercise good judgment, follow driving laws, and prioritize safety Sessions 17-18 21 for yourself, fellow motorists, and passengers. Together, we can all take action to ensure safe arrivals at our Sessions 19-21 23 respective destinations.
    [Show full text]
  • Table of Contents
    TABLE OF CONTENTS Fairboard and Committee Members 2 Purpose Of Extension 3 Schedule of Events 5 June 12 Club Entry Day Assistance Schedule 8 Cleanup Assignments 9 Entry And Conference Judging Schedule 10 Community Building and Christy 4-H Hall Hosting Schedule 11 Spirit of the Fair Award 12 General Rules 13 4-H’ers in Action 16 Queen Pageant 20 Animal Science: General Rules 22 Health Requirements 25 Beef 27 Bottle Bucket Calves 33 Dog 34 Dairy/Specialty Goat 37 Boer/Meat Goat 39 Bottle Bucket Goats 40 Horse And Pony 41 Poultry 48 Rabbit 51 Rabbit Hopping and Guinea Pig Agility 54 Sheep 56 Bottle Bucket Lambs 60 Small Pets 61 Swine 62 Livestock Judging Contest 65 Showmanship 66 Herdsmanship 67 Communication Contest 68 Fashion Revue 70 Clothing Selection 70 $15 Challenge 71 Share-the-Fun 72 Static Exhibits: General Rules 73 Elements And Principles Of Design 75 Music 76 Photography 76 Visual Arts 77 Agriculture and Natural Resources 77 Sciences And Engineering 78 Personal Development 78 Family & Consumer Sciences 78 Food & Nutrition 79 Home Improvement 79 Clothing 79 Horticulture: General Rules 81 Home Garden And Vegetable Crop 81 Fruit 83 Flower Garden and Ornamentals 84 Clover Kids 87 Story County Fair Award Donors 90 STORY COUNTY 4-H FAIR ASSOCIATION BOARD MEMBERS Member, District Position, Term Ending Wade Kahler, Cambridge President, Director at Large, 2023 Eric Finch, State Center (Southeast District) Vice-President, Director, 2024 Alice Moody, Nevada (Appointed) Secretary/Treasurer Derrick Black, Nevada (Northeast District) Director,
    [Show full text]
  • Sudafed Decongestant Tablets 12S PIL SNAS 3359 SNAS 3557 14 Mm 29.07.2021 English Rate and Blood Pressure)
    12 mm 12 mm spot = 12 x 2 centered in Distance between cutted the margin of 14 mm line/middel of the spot = 51.6 mm UK_Sudafed Decongestant Tablets 12s_PIL_SNAS 3359_SNAS 3557 14 mm 29.07.2021 English rate and blood pressure). 402059927_r2 N/A Now read this whole leaflet carefully before you use this medicine. Keep the leaflet: you ■ If you have an overactive thyroid Brochure/Leaet/Insert 145 x 250 mm might need it again. gland. 360165B BL-Val de Reuil_France ■ If you have glaucoma (increased CHILD 360165A Multi Packaging Solutions St Pierre 1 What the medicine is for pressure in the eye). 953 Oset Printing Sudafed Decongestant Tablets is a medicine used ■ If you have severe kidney problems. 8169503 PAPER to provide relief from cold, flu and allergy ■ If you are taking beta blockers (used to EMEA_2020_00006767_001 PC-0002778 symptoms such as blocked sinuses, stuffy nose treat high blood pressure). and catarrh. ■ If you are taking, or have taken in the The tablets contain pseudoephedrine last two weeks, drugs for depression ■ This medicine is used to help clear cold, flu hydrochloride, which is a decongestant that known as Monoamine Oxidase and allergy symptoms such as blocked relieves nasal and sinus congestion. Inhibitors (MAOIs) or Reversible Black PANTONE sinuses, stuffy nose and catarrh. This medicine is for use by adults and children Inhibitors of Monoamine Oxidase 3005 C ■ This medicine is for use by adults and (RIMAs). LITHO OFFSET LITHO OFFSET aged 12 years and over. children aged 12 years and over. 145 mm REPRESENTATION: Colours represented with a diagonal line have been modified to aid PDF approval.
    [Show full text]